N/A
N=20
Treatments of Acquired Apraxia of Speech
Aphasia · Apraxia of Speech · Stroke
Bottom Line
View on ClinicalTrials.gov: NCT01483807 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcome: Primary: Speech Production: Effect Size for Treated Items — 6.84; 6.14 effect size — p=.254
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Sound Production Treatment - Blocked (Behavioral); Sound Production Treatment - Random (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Sep 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Speech Production: Effect Size for Treated Items |
6.84; 6.14 | .254 |
| PRIMARY Speech Production: Percent Change in Treated Items |
46; 38 | .043 sig |
| SECONDARY Speech Production: Percent Change in Untrained Items |
14; 13 | .396 |
| SECONDARY Speech Production of Untrained Items: Effect Sizes for Untrained Items |
2.56; 2.11 | .212 |
Summary
This study was designed to examine the effects of speech therapy on ability to produce speech sounds in persons with acquired apraxia of speech.
Eligibility Criteria
Inclusion Criteria
- Must have acquired apraxia of speech that occurred following a stroke or other brain injury.
- Must be at least 6 months post-onset of brain injury.
- May have aphasia.
Exclusion Criteria
- History of drug or alcohol abuse.
- History of mental illness.
- Neurological condition other than that which resulted in apraxia of speech.
Data sourced from ClinicalTrials.gov (NCT01483807). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.